BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12095824)

  • 21. Severe course of cutaneous melanoma associated paraneoplastic retinopathy.
    Kellner U; Bornfeld N; Foerster MH
    Br J Ophthalmol; 1995 Aug; 79(8):746-52. PubMed ID: 7547786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: a new hypothesis about disease pathogenesis.
    Koreen L; He SX; Johnson MW; Hackel RE; Khan NW; Heckenlively JR
    Arch Ophthalmol; 2011 Jan; 129(1):23-9. PubMed ID: 21220625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma.
    Feigl B; Faschinger C; Soyer P
    Ophthalmologica; 2000; 214(4):271-6. PubMed ID: 10859510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma.
    Zacks DN; Pinnolis MK; Berson EL; Gragoudas ES
    Am J Ophthalmol; 2001 Oct; 132(4):578-81. PubMed ID: 11589887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous melanoma-associated retinopathy.
    Kim RY; Retsas S; Fitzke FW; Arden GB; Bird AC
    Ophthalmology; 1994 Nov; 101(11):1837-43. PubMed ID: 7800366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma-associated retinopathy: does autoimmunity prolong survival?
    Chan C; O'Day J
    Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.
    Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U
    Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
    Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
    Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction.
    Kondo M; Sanuki R; Ueno S; Nishizawa Y; Hashimoto N; Ohguro H; Yamamoto S; Machida S; Terasaki H; Adamus G; Furukawa T
    PLoS One; 2011; 6(5):e19911. PubMed ID: 21611200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Case report of melanoma-associated retinopathy associated with positive auto-antibodies against retinal bipolar cells].
    Hanaya J; Nakamura Y; Nejima R; Miyata K; Mera K; Ohguro H; Yamamoto S
    Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):541-6. PubMed ID: 21735759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.
    Jacobzone C; Cochard-Marianowski C; Kupfer I; Bettembourg S; Dordain Y; Misery L; Cochener B; Sassolas B
    Arch Dermatol; 2004 Oct; 140(10):1258-61. PubMed ID: 15492190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Slowly progressive non-neoplastic autoimmune-like retinopathy.
    Ohta K; Kikuchi T; Yoshida N
    Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):155-8. PubMed ID: 20625760
    [No Abstract]   [Full Text] [Related]  

  • 33. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
    Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ
    J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
    Dot C; Guigay J; Adamus G
    Am J Ophthalmol; 2005 Apr; 139(4):746-7. PubMed ID: 15808190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
    Milam AH; Saari JC; Jacobson SG; Lubinski WP; Feun LG; Alexander KR
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):91-100. PubMed ID: 8425845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic night blindness with malignant melanoma.
    Berson EL; Lessell S
    Am J Ophthalmol; 1988 Sep; 106(3):307-11. PubMed ID: 2971322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma-associated retinopathy associated with intranasal melanoma.
    Machida S; Ohguro H; Tateda M; Sato H; Kurosaka D
    Doc Ophthalmol; 2011 Jun; 122(3):191-7. PubMed ID: 21537930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer-associated retinopathy in a patient with hepatocellular carcinoma: case report and literature review.
    Chang PY; Yang CH; Yang CM
    Retina; 2005 Dec; 25(8):1093-6. PubMed ID: 16340542
    [No Abstract]   [Full Text] [Related]  

  • 40. Unusual aspects of melanoma. Case 3. Melanoma-associated retinopathy presenting with night blindness.
    Myers DA; Bird BR; Ryan SM; Tormey P; McKenna P; OReilly S; Breathnach OS
    J Clin Oncol; 2004 Feb; 22(4):746-8. PubMed ID: 14966102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.